Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Master Protocols In Practice

Jul 07 2017

• By Bridget Silverman

Related Content

Lung Cancer “Master Protocol” Eyed As Paradigm-Changing Approach To Drug Development

Nov 18 2013

Master Protocol For Metastatic Breast Cancer Needs To Adapt To Rational Combinations

Dec 17 2014

Lung-MAP Patient Screening Should Translate To Cost-Savings

Jun 23 2014

Genomics-Driven Trials Built To Be Fast And Flexible

Sep 21 2015

Milestones In Basket Trials: Roche's VE-BASKET And 'My Pathway'

Sep 14 2015

Tissue-Agnostic Approach To Cancer Drug Development Takes A Hit

Sep 14 2015

AML Master Protocol For Precision Medicine Developed By Nonprofit And US FDA

Dec 21 2016

I-SPY Graduates: Where Are They Now?

Jul 11 2016

Puma's Neratinib SUMMIT Study Shows Potential & Pitfalls Of Precision Medicine

Apr 03 2017

Oncology: Tissue-Agnostic Indications Advance Under US FDA's Breakthrough Umbrella

May 26 2017

Master Protocols Are Both Welcome And Inevitable – US FDA's Woodcock

Jul 07 2017

Genentech Wants Other Firms' Compounds For Mass Pediatric Cancer Screening

Mar 07 2017

Biomarkers Consortium Launches Adaptive Trial To Test Targeted Breast Cancer Drugs

Mar 19 2010

One Size No Longer Fits All: The Personalized Medicine Trial Landscape

Mar 20 2017

Q&A: FDA Dx Reviewer's Tips For Next-Gen Sequencing Sponsors

Jun 22 2017

Merck's Keytruda Offers Hope And Risk In Early Breast Cancer

Jun 06 2017

Veliparib Phase III Failures Strike Blow To AbbVie's Oncology Strategy

Apr 20 2017

Biomarkers For Pancreatic Cancer To Be Tested In Multi-drug Collaborative Study

Oct 06 2016

FDA Encourages Pediatric Master Protocols With Bayesian Approach

Sep 27 2016

Biomarker-Led Claim Is Small Step For Merck's Keytruda, Giant Leap For Cancer Indications

May 23 2017

Related Companies

Merck & Co., Inc.

Loxo Oncology at Lilly

Ignyta, Inc.

Puma Biotechnology, Inc.

AbbVie Inc.

Roche Holding AG

Novartis AG

Bristol Myers Squibb Company

Additional Topics

Clinical Trials Research & Development Review Pathway Cancer BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window